ICYMI: How Drugmakers Use a “Monopoly Extension Menu” to Block Competition

Why are some of the most expensive prescription drugs in Medicare insulated from competition long after their original patents should have expired? The answer, according to a new report from I-MAK, is Big Pharma’s “Monopoly Extension Menu.” The “Monopoly Extension Menu” is a set of legal and regulatory tactics that brand‑name drug manufacturers use to […]